$SNY Q3 '26 Earnings Results & Recap
• Reported GAAP EPS of $2.01 up 17.54% YoY
• Reported revenue of $17.25B up 11.64% YoY
• Sanofi upgraded FY 2026 guidance: sales are expected to grow by a low-teens percentage at CER, and business EPS at CER is expected to grow by a mid-teens percentage.